| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $310.2M | +24.4% |
| Cost of Revenue | $2.7M | +163.4% |
| R&D Expense | $222.2M | +35.8% |
| SG&A Expense | $155.8M | +7.8% |
| Operating Income | -$70.5M | -18.1% |
| Interest Expense | $18.8M | +265.6% |
| Pre-tax Income | -$52.9M | +13.1% |
| Income Tax | -$1.9M | +67.0% |
| Net Income | -$51.1M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $455.7M | +3.0% |
| Short-term Investments | $364.6M | — |
| Accounts Receivable | $63.0M | +21.0% |
| Inventory | $5.4M | +21.0% |
| Current Assets | $929.9M | +75.8% |
| Total Assets | $1.01B | +69.1% |
| Current Liabilities | $212.2M | +52.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $26.1M | +786.4% |
| Capital Expenditures | $5.2M | -4.6% |
| Investing Cash Flow | -$355.1M | -6446.2% |
| Financing Cash Flow | $343.9M | +901.2% |
| Free Cash Flow | $20.9M | +940.6% |
| +7.6% |
| EPS (Basic) | -$1.02 | +9.7% |
| EPS (Diluted) | -$1.02 | +9.7% |
| Total Liabilities |
| $648.8M |
| +184.4% |
| Stockholders' Equity | $360.7M | -2.2% |